Shots: The ongoing AXO-Lenti-PD (also known OXB-102) study evaluates efficacy, safety, tolerability and measuring motor function in patients with PD. The closure of initial results from study is expected in H1’19 The trial is based on results of P-I/II trial of ProSavin for its safety and efficacy, demonstrating reductions in UPDRS Part III “OFF” scores […]Read More
